Evidence mapPaperPMID 40469982Full record

ReviewFrontiers in pharmacology2025

Medicinal plants for the treatment and prevention of post-menopausal obesity: a review.

Jing Liu, Reshmi Akter, Esrat Jahan Rupa, Hoang Van-An, Jinfeng Li, Deok Chun Yang, Dong Uk Yang, Muhammad Awais, Jong-Hoon Kim

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jing Liu *Jilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun, China.
Reshmi Akter *Graduate School of Biotechnology, College of Life Sciences, Kyung Hee University, Yongin-si, Gyeonggido, Republic of Korea.
Esrat Jahan RupaGraduate School of Biotechnology, College of Life Sciences, Kyung Hee University, Yongin-si, Gyeonggido, Republic of Korea.
Hoang Van-AnMam Da Inside Joint Stock Company, Hanoi, Vietnam.
Jinfeng LiShanghai Kangfu Enterprise Management Co., LTD., Shangai, China.
Deok Chun YangGraduate School of Biotechnology, College of Life Sciences, Kyung Hee University, Yongin-si, Gyeonggido, Republic of Korea.
Dong Uk YangAIBIOME, Daejeon, Republic of Korea.
Muhammad AwaisDepartment of Biotechnology, College of Fisheries Sciences, Pukyong National University, Busan, Republic of Korea.
Jong-Hoon KimDepartment of Biotechnology, College of Fisheries Sciences, Pukyong National University, Busan, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ethnopharmacological relevance: Phytoestrogen-rich plants have been used across various traditional medicine systems, such as Ayurveda, Traditional Chinese Medicine, and Indigenous herbal practices, to address menopausal symptoms including metabolic imbalances and weight gain. The historical use of these plants underscores their therapeutic potential in women's health, providing a foundation for exploring their modern applications as safer alternatives to hormone replacement therapy (HRT) for post-menopausal obesity. Aim of the review: This review aims to systematically evaluate the anti-obesity effects of plant-derived phytoestrogens in managing post-menopausal obesity. It seeks to understand and summarize the mechanisms by which phytoestrogens act as estrogen alternatives, focusing on their cellular and molecular effects, and highlighting specific plants with promising therapeutic properties. Materials and methods: A comprehensive literature search was conducted, covering studies on phytoestrogenic plants used in traditional and contemporary practices for managing obesity. The review examines each plant's taxonomic family, common name, bioactive compounds, and experimental evidence from cellular and animal models that illustrate potential anti-obesity mechanisms relevant to post-menopausal conditions. Results: The analysis reveals that phytoestrogens employ diverse mechanisms in mitigating obesity. Some bind directly to estrogen receptors, mimicking estrogenic effects and inducing cellular responses linked to metabolism. Others inhibit adipogenesis (fat cell formation) and lipogenesis (fat storage), while some enhance thermogenesis (heat production) and lipolysis (fat breakdown), effectively counteracting the metabolic shifts associated with menopause. Specific plants, such as soy ( Conclusion: Plant-derived phytoestrogens have been proposed as a potential alternative to HRT for managing post-menopausal obesity. Drawing from both traditional ethnobotanical knowledge and emerging scientific evidence, these compounds may offer a naturally derived strategy that could carry fewer adverse effects. Nevertheless, current findings are preliminary, and more rigorous, large-scale clinical studies are necessary to better understand their efficacy, determine appropriate dosing, and assess possible interactions with conventional therapies.

Indexed as

estrogenmedicinal herbsmenopauseobesityphytoestrogen

Identifiers

PMID40469982
PMCPMC12133798

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.